F8 and von Willebrand disease (hereditary or acquired): Plasma-derived VWF and FVIII concentrates such as Wilate® and Hemate P® are the treatment options for women with type 3 VWD, type 2B VWD and types 1 and 2 VWD who do not respond to DDAVP.